Industrial Machinery & Robotics Global On demand · 24-48h

Global Robotic Sample Preparation Systems Market Strategic Research Report

Global Robotic Sample Preparation Systems Market Strategic R…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Robotic Sample Preparation Systems Market
$4962025
7.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Robotic Arm-Led, Cartesian/Gantry-Type, Collaborative Robot, Hybrid System, Others

By Application: Industrial Batch Testing, Medical Clinical Laboratories, Environmental Monitoring Stations, Universities/Research Institutes, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Autogen, BioDot, Chemspeed Technologies AG, Covaris, CTC Analytics AG, Dakewe, Diapath, GSG Robotix, Hunan zr-huxin, Metrohm, PentaBase, Prior Scientific, PT. Promanufacture Indonesia, SciGene, Sentinel Diagnostics, SepSolve Analytical, Zinsser Analytic, Siemens Healthineers, Beckman Coulter (Danaher), Roche Diagnostics, Abbott Laboratories, BD, Tecan Group, Hamilton Robotics, Greiner Bio-One, Copan Diagnostics

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 180 pages
Market size 2025
$496
Million USD
Forecast CAGR
7.4%
2025-2032
Forecast 2032
$817.5
Projected
リージョン
5
Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global Robotic Sample Preparation Systems market size is predicted to grow from US$ 496 million in 2025 to US$ 808 million in 2032; it is expected to grow at a CAGR of 7.4% from 2026 to 2032.

Robotic sample preparation systems increase laboratory productivity by using robots to minimize resource allocation for repetitive tasks such as sample weighing, extraction, filtration, dilution, and transfer to analytical equipment.

In 2024, the global production volume of robotic sample preparation systems was 14,900 units, with an average price of US$31,900 per unit. Gross profit margins typically range from 45% to 60%.

The robotic sample preparation system industry chain consists of upstream core component suppliers and downstream laboratory applications. Upstream mainly includes suppliers of key components such as precision servo motors, robotic arm joints, force control sensors, liquid handling modules, consumables, and reagents, requiring high precision, stability, and corrosion resistance. Representative upstream companies include Yaskawa Electric, Festo, and Hamilton, which provide crucial foundations in high-performance drives, automation components, and liquid handling assemblies, respectively, enabling robots to perform stable sample dispensing, pipetting, mixing, and pretreatment operations. Downstream demand is highly concentrated in research institutions, pharmaceutical companies, biotechnology companies, and third-party medical testing laboratories, especially in high-throughput screening, nucleic acid extraction, mass spectrometry sample pretreatment, and clinical testing scenarios. Major downstream representatives include Thermo Fisher's automated laboratory platforms, Roche Diagnostics' clinical sample processing systems, and large domestic third-party testing institutions such as KingMed Diagnostics. These end-users, through large-scale testing and continuously increasing demands for consistency and speed, have made robotic sample preparation systems a key efficiency tool. With increasing demand in biological research and continuous growth in testing volume, downstream has become the core driver of industry expansion.

The development trend of robotic sample preparation systems is driven by accelerated laboratory automation, faster biomedical R&D, the widespread adoption of high-throughput experiments, and rising labor costs. Automation is gradually expanding from simple pipetting to full-process sample pretreatment. Robots are deeply integrated with AI algorithms, laboratory information systems, and mass spectrometry equipment to achieve intelligent, traceable, and low-contamination-risk operating procedures. The rapid development of molecular diagnostics, cell therapy, proteomics, and synthetic biology has also significantly increased sample throughput, making robotic systems a crucial infrastructure for improving experimental efficiency and reducing human error. Obstacles include high equipment prices leading to large initial investments, the need for customized development for complex projects, increased maintenance costs and consumable reliance raising operational barriers, and the lack of standardization in some laboratory processes affecting the speed of system deployment. Limited budgets in small and medium-sized laboratories result in tiered market penetration; furthermore, high-end core components are still dominated by a few international suppliers, creating some uncertainty in the supply chain.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Robotic Sample Preparation Systems market?

What factors are driving Robotic Sample Preparation Systems market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Robotic Sample Preparation Systems market opportunities vary by end market size?

How does Robotic Sample Preparation Systems break out by Type, by Application?

This report presents a comprehensive overview of the global Robotic Sample Preparation Systems market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Robotic Arm-Led
  • Cartesian/Gantry-Type
  • Collaborative Robot
  • Hybrid System
  • Others

Segment by Automation Level

  • A1
  • A2
  • A3
  • A4
  • A5

Segment by Sample Type

  • Solid Samples
  • Liquid Samples
  • Gas/Aerosols
  • Mixtures

Segment by Application

  • Industrial Batch Testing
  • Medical Clinical Laboratories
  • Environmental Monitoring Stations
  • Universities/Research Institutes
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Robotic Sample Preparation Systems market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Industrial Batch Testing, Medical Clinical Laboratories, Environmental Monitoring Stations evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Robotic Sample Preparation Systems Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$496
2025
Forecast
$817.5
2032
CAGR
7.4%
2025–2032
リージョン
5
global
Key companies
AutogenBioDotChemspeed Technologies AGCovarisCTC Analytics AGDakeweDiapathGSG Robotix
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Robotic Arm-LedCartesian/Gantry-TypeCollaborative RobotHybrid SystemOthers
By Application
Industrial Batch TestingMedical Clinical LaboratoriesEnvironmental Monitoring StationsUniversities/Research InstitutesOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Robotic Arm-Led
  • 3.1.3 Cartesian/Gantry-Type
  • 3.1.4 Collaborative Robot
  • 3.1.5 Hybrid System
  • 3.1.6 Others
  • 3.1.7 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Industrial Batch Testing
  • 4.1.3 Medical Clinical Laboratories
  • 4.1.4 Environmental Monitoring Stations
  • 4.1.5 Universities/Research Institutes
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Autogen
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 BioDot
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Chemspeed Technologies AG
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Covaris
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 CTC Analytics AG
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Dakewe
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Diapath
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 GSG Robotix
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Hunan zr-huxin
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Metrohm
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 PentaBase
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Prior Scientific
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 PT. Promanufacture Indonesia
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 SciGene
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Sentinel Diagnostics
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 SepSolve Analytical
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Zinsser Analytic
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Siemens Healthineers
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Beckman Coulter (Danaher)
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Roche Diagnostics
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Abbott Laboratories
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 BD
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Tecan Group
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 Hamilton Robotics
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
  • 8.25 Greiner Bio-One
  • 8.25.1 Company Overview
  • 8.25.2 Key Products & Segments
  • 8.25.3 Financial Performance (2023–2025)
  • 8.25.4 Business Strategy
  • 8.25.5 SWOT Analysis
  • 8.25.6 Strategic Implications (2026–2032)
  • 8.26 Copan Diagnostics
  • 8.26.1 Company Overview
  • 8.26.2 Key Products & Segments
  • 8.26.3 Financial Performance (2023–2025)
  • 8.26.4 Business Strategy
  • 8.26.5 SWOT Analysis
  • 8.26.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Robotic Sample Preparation Systems market size?
The global Robotic Sample Preparation Systems market is estimated at US$ 496 million in 2025 (base year) and is projected to reach US$ 808 million by 2032.
What growth rate is expected for the Robotic Sample Preparation Systems market through 2032?
The market is expected to grow at a CAGR of 7.4% from 2026 to 2032, expanding from US$ 496 million in 2025 to US$ 808 million in 2032, roughly 1.6 times its base-year value.
How is Robotic Sample Preparation Systems defined?
Robotic sample preparation systems increase laboratory productivity by using robots to minimize resource allocation for repetitive tasks such as sample weighing, extraction, filtration, dilution, and transfer to analytical equipment.
What are the main segments of the Robotic Sample Preparation Systems market by type?
By type, the market is segmented into Robotic Arm-Led, Cartesian/Gantry-Type, Collaborative Robot, Hybrid System and Others.
Which applications drive demand in the Robotic Sample Preparation Systems market?
Key applications covered include Industrial Batch Testing, Medical Clinical Laboratories, Environmental Monitoring Stations, Universities/Research Institutes and Others.
Who are the key players in the Robotic Sample Preparation Systems market?
Key players profiled include Autogen, BioDot, Chemspeed Technologies AG, Covaris, CTC Analytics AG, Dakewe, Diapath and GSG Robotix, among 26 companies covered in total.
Which regions and countries are covered for Robotic Sample Preparation Systems?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Robotic Sample Preparation Systems market?
Representative upstream companies include Yaskawa Electric, Festo, and Hamilton, which provide crucial foundations in high-performance drives, automation components, and liquid handling assemblies, respectively, enabling robots to perform stable sample dispensing, pipetting, mixing, and pretreatment operations.
What challenges does the Robotic Sample Preparation Systems market face?
Obstacles include high equipment prices leading to large initial investments, the need for customized development for complex projects, increased maintenance costs and consumable reliance raising operational barriers, and the lack of standardization in some laboratory processes affecting the speed of system deployment.
Who should buy the Robotic Sample Preparation Systems market report?
The report is intended for manufacturers and solution providers, distributors and end users in Industrial Batch Testing, Medical Clinical Laboratories and Environmental Monitoring Stations, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Robotic Sample Preparation Systems market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.